254 studies found for:    Open Studies | "Parasitic Diseases"
Show Display Options
Rank Status Study
1 Recruiting Parasitic Infections of the Gastrointestinal Tract
Conditions: Amebiasis;   Cryptosporidiosis;   Giardiasis;   Parasitic Disease;   Parasitic Intestinal Disease
Intervention:
2 Recruiting Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection
Conditions: Chagas Disease;   Malaria;   Parasitic Disease;   Trypanosomiasis
Intervention:
3 Not yet recruiting Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Condition: Head Lice Infestation
Interventions: Drug: Abametapir Lotion 0.74% w/w;   Drug: Vehicle Lotion
4 Recruiting Phase 3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
Condition: Head Lice Infestation
Intervention: Drug: Abametapir Lotion 0.74% w/w
5 Recruiting P3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
Condition: Head Lice Infestation
Intervention: Drug: Abametapir Lotion 0.74% w/w
6 Recruiting A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation
Condition: Head Lice Infestation
Intervention: Drug: Ha44 Gel 0.74% w/w
7 Recruiting Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
Conditions: Asthma;   Eosinophilia;   Helminthiasis;   Hypersensitivity;   Parasitic Disease
Intervention:
8 Unknown  Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158
Conditions: Trypanosomiasis;   Trypanosomiasis, African;   Protozoan Infections;   Parasitic Diseases
Interventions: Drug: SCYX-7158;   Drug: Placebo
9 Recruiting Evaluation and Long-Term Follow-up of Patients With Inflammatory Disorders
Conditions: Bacterial Infection and Mycoses;   Immunologic Disease;   Inflammation;   Parasitic Disease;   Virus Disease
Intervention:
10 Available Compassionate Use of Triclabendazole for the Treatment of Parasites (Prior to FDA Approval; Expanded Access Program)
Condition: Parasitic Disease
Intervention: Drug: Triclabendazole
11 Unknown  Effectiveness of Permethrin Impregnated Underwear in Preventing Louse Proliferation in Infected Homeless
Condition: Lice
Interventions: Drug: Permethrin impregnated;   Drug: no Permethrin impregnated
12 Not yet recruiting Efficacy and Safety Study for PIOLIN® Shampoo
Condition: PEDICULOSIS
Interventions: Drug: PIOLIN®;   Drug: NEDAX
13 Recruiting A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of PF-045 and PF-055 for the Treatment of Scabies
Condition: Scabies
Interventions: Drug: PF-045;   Drug: PF-055;   Drug: Vehicle
14 Recruiting Evaluation of a Rapid Diagnostic Device, CL Detect, for the Diagnosis of Cutaneous Leishmaniasis in Tunisia
Condition: Skin Diseases, Parasitic
Intervention: Other: No Intervention
15 Not yet recruiting Postpartum Deworming: Improving Breastfeeding and Optimizing Infant Growth
Condition: Intestinal Diseases, Parasitic
Intervention: Drug: Albendazole
16 Not yet recruiting Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya
Conditions: Cryptosporidium;   Cryptosporidiosis;   Waterborne Disease;   Diarrheal Disease
Intervention: Other: Ceramic water filter
17 Recruiting Breast Milk Composition and HIV-exposed/Unexposed Early Infant Growth and Infectious Disease Events
Conditions: HIV;   Malnutrition;   Cryptosporidiosis
Intervention:
18 Unknown  Babesia Testing in Blood Donors
Condition: Transfusion Transmitted Babesiosis
Intervention: Biological: B.microti diagnostic blood tests
19 Unknown  Treatment of Asymptomatic Toxocariasis With Albendazole in Children
Condition: Asymptomatic Toxocariasis
Interventions: Drug: Albendazole;   Drug: Placebo
20 Recruiting Assessment of Two Therapeutic Strategies in the Treatment of Children With Congenital Toxoplasmosis
Condition: Congenital Toxoplasmosis
Interventions: Procedure: reducing treatment to 3 months;   Procedure: registered length of treatment

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years